Company
Shedir Pharma Group S.p.A.
Headquarters: Naples, Italy
Employees: 66
CEO: Mr. Antonio Scala
Market Cap
€44.3 Million
EUR as of July 1, 2024
US$47.6 Million
Shedir Pharma Group S.p.A. Categories
Italy Healthcare Drug Manufacturers—Specialty & GenericItaly Healthcare Italy Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Shedir Pharma Group S.p.A., through its subsidiaries, engages in the medical and pharmaceutical business in Italy. It engages in the research, development, and marketing of nutraceuticals, cosmetics, and medical devices. The company offers products for andrological, cardiovascular, dermatological, hematological, energy, gastrointestinal, gynecological, metabolic, neurological, dental, ophthalmic, osteoarticular, ontological, respiratory, and trichological disorders. The company was founded in 2008 and is based in Naples, Italy.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Shedir Pharma Group S.p.A. has the following listings and related stock indices.
Stock: MTA: SHE wb_incandescent